Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NexQloud Announces Deployment of Over 750 NanoServers Across Five Countries, Achieving 75% of Launch Target
-
L3Harris Awards CPI Aerostructures, Inc. Contract for Next Generation Jammer Low-Band Program
-
RTI Connext Drive at CES 2025: The Leading Communication Framework for Accelerating SDV Development
-
Enphase Energy Begins Shipments of IQ8X and IQ8 Commercial Microinverters with Higher Domestic Content
-
Canada’s National Farm Leadership Program Now Accepting Applications
-
OnTerra Systems Announces Availability of New, Free Guide Comparing The Google Maps API Vs. RouteSavvy API PLUS
-
LKQ Corporation Continues Board Refreshment with the Appointment of James S. Metcalf
-
Clip Money Announces Rapid Customer Adoption of its Cash and Change Delivery Service
-
AgEagle Aerial Systems Receives Green UAS Certification Validating its Drone Technologies to Serve the Commercial and Non-Defense Drone Market
-
Nano Dimension’s Additive Electronics Product Line - Essemtec - Received a Global Technology Award
-
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures
-
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer
-
NANO Nuclear Energy Appoints Distinguished Engineer and Leader Michael Norato, Ph.D. as Director of Nuclear Facilities and Infrastructure
-
VERSES Releases Latest Version of Genius™
-
TransUnion 2025 Consumer Credit Forecast Points to Moderating Credit Card Balance Growth and Slower Delinquency Gains
-
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
-
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
-
Chart Industries, Inc. Announces $250 Million Share Repurchase Authorization
-
WillScot Announces Executive Leadership Transitions
-
FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER
-
ValueRock Celebrates Grand Opening of The Commons with Diverse Retailer Roster and New Acquisitions
-
SUPERIOR GROUP OF COMPANIES TO PARTICIPATE IN SINGULAR RESEARCH’S 19th ANNUAL BEST OF THE UNCOVEREDS CONFERENCE
-
Well+Good Launches Annual Wellness Trends Report
-
Timbercreek North American Mortgage Fund Surpasses US$600 Million AUM
-
AXIL Brands and NASCAR Renew Product License Agreement Through 2027
-
GlobeTopper Reports 37% MoM Revenue Growth to $4.05 Million, Driven by Strong Cryptocurrency Expansion and Digital Gift Card Demand
-
Greif Inc. Hosts 2024 Investor Day
-
FuelCell Energy Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call on December 19, 2024 at 10 A.M. Eastern Time
-
Endeavour Announces Holding(s) in Company
-
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
-
Alliance Witan PLC - Net Asset Value
-
Man Group PLC : Form 8.3 - International Distribution Services plc
-
Man Group PLC : Form 8.3 - Britvic plc
-
BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®
-
Man Group PLC : Form 8.3 - Spirent Communications plc
-
Man Group PLC : Form 8.3 - Direct Line Insurance Group plc
-
Future Technologies Launches Advisory Services, Providing Expert Guidance to Customers in Their Connectivity Transformation Journey
-
Man Group PLC : Form 8.3 - Aviva plc
-
Clean Motion appoints Louise Jeansson as Chief Communications & Marketing Officer
-
Demesne Resources Ltd. Announces Listing on Frankfurt Stock Exchange & Appointment of Strategic Technical Advisors
-
Abaxx to Launch Nickel Sulphate Futures on January 10, 2025
-
AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed
-
Prime Drink Group Announces a Massive Production Increase for Glutenberg and its Return to Shelves: Thousands of Outlets in Canada and the U.S. Soon to be Supplied
-
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Po
-
Prodege and McDougall Communications Forge Innovative Partnership to Advance Vision Correction Research
-
Global Crossing Airlines Announces Director Resignation
-
Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignan
-
Reunion Neuroscience Presented RE104 Phase 1 Data at the 2024 American College of Neuropsychopharmacology (ACNP) 63rd Annual Meeting
-
Holding(s) in Company
-
Signature Aviation and Eve Air Mobility to Research Ecosystem Requirements and Services for Advanced Air Mobility Ground Operations

